Skip to main content Accessibility help
×
Home

How reliable and robust are current biomarkers for copper status? – reply by Danzeisen et al.

  • Ruth Danzeisen (a1), Magdalena Araya (a2), Brenda Harrison (a3), Carl Keen (a4), Marc Solioz (a5), Dennis Thiele (a6) and Harry J. McArdle (a7)...

Extract

The response by Brewer & Althaus to our recent review on biomarkers for Cu(1) bears testimony that the subject is topical and of public, scientific and commercial interest.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      How reliable and robust are current biomarkers for copper status? – reply by Danzeisen et al.
      Available formats
      ×

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      How reliable and robust are current biomarkers for copper status? – reply by Danzeisen et al.
      Available formats
      ×

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      How reliable and robust are current biomarkers for copper status? – reply by Danzeisen et al.
      Available formats
      ×

Copyright

References

Hide All
1Danzeisen, R, Araya, M, Harrison, B, Keen, C, Solioz, M, Thiele, D & McArdle, HJM (2007) How reliable and robust are current biomarkers for copper status? Br J Nutr 98, 676683.
2Nishihara, E, Furuyama, T, Yamashita, S & Mori, N (1998) Expression of copper trafficking genes in the mouse brain. Neuroreport 9, 32593263.
3Kuo, YM, Gybina, AA, Pyatskowit, JW, Gitschier, J & Prohaska, JR (2006) Copper transport protein (Ctr1) levels in mice are tissue specific and dependent on copper status. J Nutr 136, 2126.
4Rae, TD, Schmidt, PJ, Pufahl, RA, Culotta, VC & O'Halloran, TV (1999) Undetectable intracellular free copper: the requirement of a copper chaperone for superoxide dismutase. Science 284, 805808.
5Brewer, GJ (2007) Iron and copper toxicity in diseases of aging, particularly atherosclerosis and Alzheimer's disease. Exp Biol Med (Maywood) 232, 323335.
6Phinney, AL, Drisaldi, B, Schmidt, SD, et al. (2003) In vivo reduction of amyloid-β by a mutant copper transporter. Proc Natl Acad Sci U S A 100, 1419314198.
7Bayer, TA, Schafer, S, Simons, A, et al. (2003) Dietary Cu stabilizes brain superoxide dismutase 1 activity and reduces amyloid Aβ production in APP23 transgenic mice. Proc Natl Acad Sci U S A 100, 1418714192.
8Pajonk, FG, Kessler, H, Supprian, T, et al. (2005) Cognitive decline correlates with low plasma concentrations of copper in patients with mild to moderate Alzheimer's disease. J Alzheimers Dis 8, 2327.
9Squitti, R, Ventriglia, M, Barbati, G, et al. (2007) ‘Free’ copper in serum of Alzheimer's disease patients correlates with markers of liver function. J Neural Transm 114, 15891594.
10Religa, D, Strozyk, D, Cherny, RA, Volitakis, I, Haroutunian, V, Winblad, B, Naslund, J & Bush, AI (2006) Elevated cortical zinc in Alzheimer disease. Neurology 67, 6975.

How reliable and robust are current biomarkers for copper status? – reply by Danzeisen et al.

  • Ruth Danzeisen (a1), Magdalena Araya (a2), Brenda Harrison (a3), Carl Keen (a4), Marc Solioz (a5), Dennis Thiele (a6) and Harry J. McArdle (a7)...

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed